Turkey tail mushroom
•Last Updated: September 28 2022
Turkey Tail Mushroom (Trametes versicolor) is a mushroom that is a source of a polysaccharide, known as polysaccharide K, that is established as a cancer adjunct therapy for the immune system.
Turkey tail mushroom is most often used for
Last Updated: September 28 2022
Note that Turkey tail mushroom is also known as:
- Turkey Tail Mushroom
- Coriolus Versicolor
- Polyporus Versicolor
- Trametes Versicolor
What works and what doesn't?
Unlock the full potential of Examine
1.^Sullivan R, Smith JE, Rowan NJMedicinal mushrooms and cancer therapy: translating a traditional practice into Western medicinePerspect Biol Med.(2006 Spring)
2.^Fisher M, Yang LXAnticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapyAnticancer Res.(2002 May-Jun)
3.^Sakagami H, Sugaya K, Utsumi A, Fujinaga S, Sato T, Takeda MStimulation by PSK of interleukin-1 production by human peripheral blood mononuclear cellsAnticancer Res.(1993 May-Jun)
4.^Zaidman BZ, Yassin M, Mahajna J, Wasser SPMedicinal mushroom modulators of molecular targets as cancer therapeuticsAppl Microbiol Biotechnol.(2005 Jun)
5.^Hsieh TC, Kunicki J, Darzynkiewicz Z, Wu JMEffects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta,-6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytesJ Altern Complement Med.(2002 Oct)
6.^Chan SL, Yeung JHPolysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouseLife Sci.(2006 Apr 18)
7.^Kato M, Hirose K, Hakozaki M, Ohno M, Saito Y, Izutani R, Noguchi J, Hori Y, Okumoto S, Kuroda D, et alInduction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharideCancer Immunol Immunother.(1995 Mar)
8.^Lu H, Yang Y, Gad E, Wenner CA, Chang A, Larson ER, Dang Y, Martzen M, Standish LJ, Disis MLPolysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cellsClin Cancer Res.(2011 Jan 1)
9.^Azuma M, Sawahata R, Akao Y, Ebihara T, Yamazaki S, Matsumoto M, Hashimoto M, Fukase K, Fujimoto Y, Seya TThe peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activationPLoS One.(2010 Sep 2)
10.^Martinez J, Huang X, Yang YDirect TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infectionPLoS Pathog.(2010 Mar 12)
11.^Torkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, Gay J, Putiri A, Standish LJPhase 1 Clinical Trial of Trametes versicolor in Women with Breast CancerISRN Oncol.(2012)
12.^Liu A, Arbiser JL, Holmgren A, Klein G, Klein EPSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12Blood.(2005 Feb 15)
13.^Lu H, Yang Y, Gad E, Inatsuka C, Wenner CA, Disis ML, Standish LJTLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapyClin Cancer Res.(2011 Nov 1)
14.^Moreno M, Mol BM, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJToll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)Cancer Lett.(2008 Dec 8)
15.^Pathmanathan N, Bilous AMHER2 testing in breast cancer: an overview of current techniques and recent developmentsPathology.(2012 Dec)
Primary Use